{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:33:51Z","timestamp":1790314431983,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00280-019-03775-9","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T11:46:24Z","timestamp":1548675984000},"page":"775-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP"],"prefix":"10.1007","volume":"83","author":[{"given":"E.","family":"Baudry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Verny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Madar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Urien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-3102","authenticated-orcid":false,"given":"Keyvan","family":"Rezai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"3775_CR1","unstructured":"World Health Organization, National Institute on Aging, National Institutes of Health, U.S. Department of Health and Human Services (2011) Global health and aging. \n                    https:\/\/www.nia.nih.gov\/research\/publication\/global-health-and-aging\/overview\n                    \n                  . Accessed 12 Feb 2017"},{"key":"3775_CR2","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. World population prospects, the 2017 revision. \n                    https:\/\/esa.un.org\/unpd\/wpp\/\n                    \n                  . Accessed 12 Feb 2017"},{"key":"3775_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2017.06.001","author":"E Soto-Perez-de-Celis","year":"2017","unstructured":"Soto-Perez-de-Celis E, de Glas NA, Hsu T, Kanesvaran R, Steer C, Navarrete-Reyes AP, Battisti NML, Chavarri-Guerra Y, O\u2019Donovan A, Avila-Funes JA, Hurria A (2017) Global geriatric oncology: achievements and challenges. J Geriatr Oncol. \n                    https:\/\/doi.org\/10.1016\/j.jgo.2017.06.001\n                    \n                   ([Epub ahead of print] Review. PubMed PMID: 28642040)","journal-title":"J Geriatr Oncol"},{"key":"3775_CR4","unstructured":"The World Bank (2018) World Development Indicators. Life expectancy at birth, total (years). \n                    http:\/\/data.worldbank.org\/indicator\/SP.DYN.LE00.IN\n                    \n                  . Accessed 23 Sept 2016"},{"issue":"1","key":"3775_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0889-8588(05)70274-4","volume":"14","author":"L Balducci","year":"2000","unstructured":"Balducci L, Extermann M (2000) Cancer and aging. An evolving panorama. Hematol Oncol Clin N Am 14(1):1\u201316 (Review. PubMed PMID: 10680068)","journal-title":"Hematol Oncol Clin N Am"},{"issue":"7","key":"3775_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1317::AID-CNCR18>3.0.CO;2-A","volume":"80","author":"L Balducci","year":"1997","unstructured":"Balducci L, Extermann M (1997) Cancer chemotherapy in the older patient: what the medical oncologist needs to know. Cancer 80(7):1317\u20131322 (Review. PubMed PMID: 9317185)","journal-title":"Cancer"},{"key":"3775_CR7","doi-asserted-by":"publisher","first-page":"F21","DOI":"10.1684\/bdc.2007.0541","volume":"95","author":"B Tranchand","year":"2008","unstructured":"Tranchand B, Falandry C, You B, Girard P, Ribba B, Tod M, Freyer G (2008) Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment. Bull Cancer 95:F21\u2013F27. \n                    https:\/\/doi.org\/10.1684\/bdc.2007.0541\n                    \n                   (French. PubMed PMID: 18511363)","journal-title":"Bull Cancer"},{"issue":"13","key":"3775_CR8","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/rcm.1508","volume":"18","author":"D Kasel","year":"2004","unstructured":"Kasel D, Jetter A, Harlfinger S, Gebhardt W, Fuhr U (2004) Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography\/tandem mass spectrometry. Rapid Commun Mass Spectrom 18(13):1472\u20131478 (PubMed PMID: 15216508)","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"1\u20132","key":"3775_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jchromb.2005.08.017","volume":"826","author":"CM Gilbert","year":"2005","unstructured":"Gilbert CM, McGeary RP, Filippich LJ, Norris RL, Charles BG (2005) Simultaneous liquid chromatographic determination of doxorubicin and its major metabolite doxorubicinol in parrot plasma. J Chromatogr B Anal Technol Biomed Life Sci 826(1\u20132):273\u2013276 (Epub 2005 Sep 15. PubMed PMID: 16168722)","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"3775_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/bjaceaccp\/mkh042","volume":"4","author":"LE Baerdemaeker De","year":"2004","unstructured":"De Baerdemaeker LE, Mortier EP, Struys MM (2004) PK in obese patients. Contin Educ Anaesth Crit Care Pain 4:152\u2013155","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"3775_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8010006","author":"MR Crombag","year":"2016","unstructured":"Crombag MR, Joerger M, Th\u00fcrlimann B, Schellens JH, Beijnen JH, Huitema AD (2016) PK of selected anticancer drugs in elderly cancer patients: focus on breast cancer. Cancers (Basel). \n                    https:\/\/doi.org\/10.3390\/cancers8010006\n                    \n                   (PubMed PMID: 26729170; PubMed Central PMCID: PMC4728453)","journal-title":"Cancers (Basel)"},{"issue":"7","key":"3775_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11606-010-1629-x","volume":"26","author":"DM Zulman","year":"2011","unstructured":"Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA (2011) Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 26(7):783\u2013790. \n                    https:\/\/doi.org\/10.1007\/s11606-010-1629-x\n                    \n                   (Epub 2011 Feb 1. Review. PubMed PMID: 21286840; PubMed Central PMCID: PMC3138606)","journal-title":"J Gen Intern Med"},{"issue":"4","key":"3775_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2165\/00003088-200746040-00005","volume":"46","author":"S Wilde","year":"2007","unstructured":"Wilde S, Jetter A, Rietbrock S, Kasel D, Engert A, Josting A, Klimm B, Hempel G, Reif S, Jaehde U, Merkel U, Busse D, Schwab M, Diehl V, Fuhr U (2007) Population PK of the BEACOPP polychemotherapy regimen in Hodgkin\u2019s lymphoma and its effect on myelotoxicity. Clin Pharmacokinet 46(4):319\u2013333 (PubMed PMID: 17375983)","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"3775_CR14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2165\/00003088-200746120-00005","volume":"46","author":"M Joerger","year":"2007","unstructured":"Joerger M, Huitema AD, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E, Vermorken JB, Strocchi E, Martoni A, Sorio R, Sleeboom HP, Izquierdo MA, Jodrell DI, F\u00e9ty R, de Bruijn E, Hempel G, Karlsson M, Tranchand B, Schrijvers AH, Twelves C, Beijnen JH, Schellens JH (2007) EORTC-PAMM-NDDG. Population PK and PD of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG. Clin Pharmacokinet 46(12):1051\u20131068 (PubMed PMID: 18027989)","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3775_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/clpt.1993.69","volume":"53","author":"SC Piscitelli","year":"1993","unstructured":"Piscitelli SC, Rodvold KA, Rushing DA, Tewksbury DA (1993) PK and PD of doxorubicin in patients with small cell lung cancer. Clin Pharmacol Ther 53(5):555\u2013561 (PubMed PMID: 8387903)","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3775_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00007691-198901000-00002","volume":"11","author":"TW Sweatman","year":"1989","unstructured":"Sweatman TW, Lokich JJ, Israel M (1989) Clinical pharmacology of continuous infusion doxorubicin. Ther Drug Monit 11(1):3\u20139 (PubMed PMID: 2911850)","journal-title":"Ther Drug Monit"},{"issue":"8","key":"3775_CR17","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.ejca.2003.12.026","volume":"40","author":"MA Rudek","year":"2004","unstructured":"Rudek MA, Sparreboom A, Garrett-Mayer ES, Armstrong DK, Wolff AC, Verweij J, Baker SD (2004) Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy. Eur J Cancer 40(8):1170\u20131178 (PubMed PMID: 15110880)","journal-title":"Eur J Cancer"},{"issue":"6","key":"3775_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/BF00685796","volume":"36","author":"NA Dobbs","year":"1995","unstructured":"Dobbs NA, Twelves CJ, Gillies H, James CA, Harper PG, Rubens RD (1995) Gender affects doxorubicin PK in patients with normal liver biochemistry. Cancer Chemother Pharmacol 36(6):473\u2013476 (PubMed PMID: 7554038)","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3775_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-014-2843-8","volume":"144","author":"AL Wong","year":"2014","unstructured":"Wong AL, Seng KY, Ong EM, Wang LZ, Oscar H, Cordero MT, Copones R, Fan L, Tan SH, Goh BC, Lee SC (2014) Body fat composition impacts the hematologic toxicities and PK of doxorubicin in Asian breast cancer patients. Breast Cancer Res Treat 144(1):143\u2013152. \n                    https:\/\/doi.org\/10.1007\/s10549-014-2843-8\n                    \n                   (Epub 2014 Jan 31. PubMed PMID: 24481679)","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3775_CR20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00280-002-0554-z","volume":"51","author":"J Li","year":"2003","unstructured":"Li J, Gwilt PR (2003) The effect of age on the early disposition of doxorubicin. Cancer Chemother Pharmacol 51(5):395\u2013402 (Epub 2003 Apr 1. PubMed PMID: 12679882)","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3775_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1006\/bbrc.1994.1971","volume":"202","author":"AR Safa","year":"1994","unstructured":"Safa AR, Roberts S, Agresti M, Fine RL (1994) Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells. Biochem Biophys Res Commun 202(1):606\u2013612 (PubMed PMID: 7913604)","journal-title":"Biochem Biophys Res Commun"},{"key":"3775_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","volume":"39","author":"SV Ambudkar","year":"1999","unstructured":"Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361\u2013398 (Review. PubMed PMID: 10331089)","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"3775_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jgo.2011.11.008","volume":"3","author":"JM Tourani","year":"2012","unstructured":"Tourani JM, Mourey L, Servent V, Nguyen T, Ravaud A, Girre V, Favrel S, Pinel MC, Isambert N (2012) Influence of age on the PK of i.v. vinflunine: results of a phase I trial in elderly cancer patients. J Geriatr Oncol 3(1):41\u201348 (ISSN 1879-4068)","journal-title":"J Geriatr Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03775-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T19:08:49Z","timestamp":1580152129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03775-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3775"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03775-9","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"22 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors has conflicts of interest directly related to the contents of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}